226 related articles for article (PubMed ID: 27016466)
1. A comprehensive review of the neonatal Fc receptor and its application in drug delivery.
Martins JP; Kennedy PJ; Santos HA; Barrias C; Sarmento B
Pharmacol Ther; 2016 May; 161():22-39. PubMed ID: 27016466
[TBL] [Abstract][Full Text] [Related]
2. FcRn mediates fast recycling of endocytosed albumin and IgG from early macropinosomes in primary macrophages.
Toh WH; Louber J; Mahmoud IS; Chia J; Bass GT; Dower SK; Verhagen AM; Gleeson PA
J Cell Sci; 2019 Oct; 133(5):. PubMed ID: 31444284
[TBL] [Abstract][Full Text] [Related]
3. Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor.
Tesar DB; Tiangco NE; Bjorkman PJ
Traffic; 2006 Sep; 7(9):1127-42. PubMed ID: 17004319
[TBL] [Abstract][Full Text] [Related]
4. FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions.
Challa DK; Velmurugan R; Ober RJ; Sally Ward E
Curr Top Microbiol Immunol; 2014; 382():249-72. PubMed ID: 25116104
[TBL] [Abstract][Full Text] [Related]
5. Neonatal Fc Receptor Regulation of Lung Immunoglobulin and CD103+ Dendritic Cells Confers Transient Susceptibility to Tuberculosis.
Vogelzang A; Lozza L; Reece ST; Perdomo C; Zedler U; Hahnke K; Oberbeck-Mueller D; Dorhoi A; Kaufmann SH
Infect Immun; 2016 Oct; 84(10):2914-21. PubMed ID: 27481246
[TBL] [Abstract][Full Text] [Related]
6. FcRn: the neonatal Fc receptor comes of age.
Roopenian DC; Akilesh S
Nat Rev Immunol; 2007 Sep; 7(9):715-25. PubMed ID: 17703228
[TBL] [Abstract][Full Text] [Related]
7. The immunologic functions of the neonatal Fc receptor for IgG.
Rath T; Kuo TT; Baker K; Qiao SW; Kobayashi K; Yoshida M; Roopenian D; Fiebiger E; Lencer WI; Blumberg RS
J Clin Immunol; 2013 Jan; 33 Suppl 1(Suppl 1):S9-17. PubMed ID: 22948741
[TBL] [Abstract][Full Text] [Related]
8. The multiple facets of FcRn in immunity.
Stapleton NM; Einarsdóttir HK; Stemerding AM; Vidarsson G
Immunol Rev; 2015 Nov; 268(1):253-68. PubMed ID: 26497526
[TBL] [Abstract][Full Text] [Related]
9. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
[TBL] [Abstract][Full Text] [Related]
10. The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy.
Sockolosky JT; Szoka FC
Adv Drug Deliv Rev; 2015 Aug; 91():109-24. PubMed ID: 25703189
[TBL] [Abstract][Full Text] [Related]
11. The Neonatal Fc Receptor (FcRn): A Misnomer?
Pyzik M; Sand KMK; Hubbard JJ; Andersen JT; Sandlie I; Blumberg RS
Front Immunol; 2019; 10():1540. PubMed ID: 31354709
[TBL] [Abstract][Full Text] [Related]
12. A strategy for bacterial production of a soluble functional human neonatal Fc receptor.
Andersen JT; Justesen S; Berntzen G; Michaelsen TE; Lauvrak V; Fleckenstein B; Buus S; Sandlie I
J Immunol Methods; 2008 Feb; 331(1-2):39-49. PubMed ID: 18155020
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of intracellular neonatal Fc receptor-ligand interactions in primary macrophages using biophysical fluorescence techniques.
Pannek A; Houghton FJ; Verhagen AM; Dower SK; Hinde E; Gleeson PA
Mol Biol Cell; 2022 Jan; 33(1):ar6. PubMed ID: 34731029
[TBL] [Abstract][Full Text] [Related]
14. Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer.
Porter C; Armstrong-Fisher S; Kopotsha T; Smith B; Baker T; Kevorkian L; Nesbitt A
J Reprod Immunol; 2016 Aug; 116():7-12. PubMed ID: 27123565
[TBL] [Abstract][Full Text] [Related]
15. FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus.
Kim J; Mohanty S; Ganesan LP; Hua K; Jarjoura D; Hayton WL; Robinson JM; Anderson CL
J Immunol; 2009 Mar; 182(5):2583-9. PubMed ID: 19234152
[TBL] [Abstract][Full Text] [Related]
16. The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics.
Andersen JT; Sandlie I
Drug Metab Pharmacokinet; 2009; 24(4):318-32. PubMed ID: 19745559
[TBL] [Abstract][Full Text] [Related]
17. Neonatal Fc receptor: from immunity to therapeutics.
Kuo TT; Baker K; Yoshida M; Qiao SW; Aveson VG; Lencer WI; Blumberg RS
J Clin Immunol; 2010 Nov; 30(6):777-89. PubMed ID: 20886282
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model.
Kim J; Hayton WL; Robinson JM; Anderson CL
Clin Immunol; 2007 Feb; 122(2):146-55. PubMed ID: 17046328
[TBL] [Abstract][Full Text] [Related]
19. Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury.
Pyzik M; Rath T; Kuo TT; Win S; Baker K; Hubbard JJ; Grenha R; Gandhi A; Krämer TD; Mezo AR; Taylor ZS; McDonnell K; Nienaber V; Andersen JT; Mizoguchi A; Blumberg L; Purohit S; Jones SD; Christianson G; Lencer WI; Sandlie I; Kaplowitz N; Roopenian DC; Blumberg RS
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2862-E2871. PubMed ID: 28330995
[TBL] [Abstract][Full Text] [Related]
20. FcRn expression in cancer: Mechanistic basis and therapeutic opportunities.
Rudnik-Jansen I; Howard KA
J Control Release; 2021 Sep; 337():248-257. PubMed ID: 34245786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
